CARMIEL, Israel, Jan. 13 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE-Amex: PLX), announced today that the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency...
CHICAGO, Jan. 5 /PRNewswire/ -- Seven Summits Research issues PriceWatch Alerts for PFE, HPQ, AMAT, PPG, and AU. Seven Summits Strategic Investments' PriceWatch Alerts are available at...
CHICAGO, Oct. 14 /PRNewswire/ -- Seven Summits Research issues PriceWatch Alerts for PFE, HIG, STI, TSM, and LEN. Seven Summits Strategic Investments' PriceWatch Alerts are available at...
SCHAUMBURG, Ill., Oct. 1 /PRNewswire-USNewswire/ -- In an effort to help U.S. veterinary students cope with rising school debt while reinforcing the importance of building a diverse profession...
ROCHESTER, N.Y., April 15 /PRNewswire/ -- TopBestPennyStocks.com is pleased to offer its stock alerts service to the investing community. Investors who are interested in stocks on the move and...
DALLAS, Feb. 18 /PRNewswire/ -- BeaconEquity.com announces the availability of Trade Alerts on stocks making news today. Investors can view all of the daily trading notes for free by visiting:...
The Only-Approved Cholesterol-Lowering Medication for Reducing the Risk of Hospitalization for Heart Failure NEW YORK, March 7 /PRNewswire-FirstCall/ -- Pfizer announced today that the U.S. Food...
Real-World Implications for Patients, Providers and Healthcare Systems Seeking Quality Care; Pfizer to Further Explore These Benefits in Partnership with Others BUENA VISTA, Fla., March 2...
Pivotal Data Presented at the 14th Conference on Retroviruses and Opportunistic Infections (CROI) LOS ANGELES, March 1 /PRNewswire-FirstCall/ -- At this week's major HIV/AIDS research meeting...
NEW YORK, Feb. 27 /PRNewswire-FirstCall/ -- Pfizer Inc said today that a federal court in the Western District of Pennsylvania (Pittsburgh) has upheld the company's U.S. patent covering the...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.